CLDXCelldex Therapeutics, Inc.Feb 28, 2022Q4 2021
Read transcript →Celldex Therapeutics, Inc. (CLDX) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$38.69
+2.65%
Mkt Cap $2.37B
CLDXCelldex Therapeutics, Inc.Feb 28, 2022CLDXCelldex Therapeutics, Inc.Aug 6, 2020Q2 2020
Read transcript →CLDXCelldex Therapeutics, Inc.Aug 8, 2019Q2 2019
Read transcript →CLDXCelldex Therapeutics, Inc.Mar 7, 2019Q4 2018
Read transcript →CLDXCelldex Therapeutics, Inc.Aug 8, 2018Q2 2018
Read transcript →CLDXCelldex Therapeutics, Inc.Mar 7, 2018Q3 2017
Read transcript →CLDXCelldex Therapeutics, Inc.Aug 8, 2017Q2 2017
Read transcript →CLDXCelldex Therapeutics, Inc.Mar 14, 2017Q4 2016
Read transcript →CLDXCelldex Therapeutics, Inc.Aug 8, 2016Q2 2016
Read transcript →CLDXCelldex Therapeutics, Inc.Feb 25, 2016Q4 2015
Read transcript →CLDXCelldex Therapeutics, Inc.Aug 10, 2015Q2 2015
Read transcript →CLDXCelldex Therapeutics, Inc.Feb 24, 2015Q4 2014
Read transcript →CLDXCelldex Therapeutics, Inc.Aug 6, 2014Q2 2014
Read transcript →CLDXCelldex Therapeutics, Inc.Mar 3, 2014Q4 2013
Read transcript →CLDXCelldex Therapeutics, Inc.Mar 7, 2013Q4 2012
Read transcript →CLDXCelldex Therapeutics, Inc.Aug 10, 2012Q2 2012
Read transcript →